Correlation Between Dynavax Technologies and Citius Oncology,
Can any of the company-specific risk be diversified away by investing in both Dynavax Technologies and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dynavax Technologies and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dynavax Technologies and Citius Oncology,, you can compare the effects of market volatilities on Dynavax Technologies and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dynavax Technologies with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dynavax Technologies and Citius Oncology,.
Diversification Opportunities for Dynavax Technologies and Citius Oncology,
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Dynavax and Citius is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Dynavax Technologies and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and Dynavax Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dynavax Technologies are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of Dynavax Technologies i.e., Dynavax Technologies and Citius Oncology, go up and down completely randomly.
Pair Corralation between Dynavax Technologies and Citius Oncology,
Given the investment horizon of 90 days Dynavax Technologies is expected to generate 0.15 times more return on investment than Citius Oncology,. However, Dynavax Technologies is 6.61 times less risky than Citius Oncology,. It trades about 0.0 of its potential returns per unit of risk. Citius Oncology, is currently generating about -0.15 per unit of risk. If you would invest 1,390 in Dynavax Technologies on September 12, 2024 and sell it today you would lose (105.00) from holding Dynavax Technologies or give up 7.55% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 24.15% |
| Values | Daily Returns |
Dynavax Technologies vs. Citius Oncology,
Performance |
| Timeline |
| Dynavax Technologies |
| Citius Oncology, |
Dynavax Technologies and Citius Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dynavax Technologies and Citius Oncology,
The main advantage of trading using opposite Dynavax Technologies and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dynavax Technologies position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.| Dynavax Technologies vs. Evoke Pharma | Dynavax Technologies vs. Amphastar P | Dynavax Technologies vs. Lantheus Holdings | Dynavax Technologies vs. ANI Pharmaceuticals |
| Citius Oncology, vs. Evoke Pharma | Citius Oncology, vs. Dynavax Technologies | Citius Oncology, vs. Amphastar P | Citius Oncology, vs. Lantheus Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |